Newly FDA Approved Ketamine Has the Potential to Slow ALS Progression
qimono / Pixabay

Newly FDA Approved Ketamine Has the Potential to Slow ALS Progression

An October 2021 report published in the Globe and Newswire carried an announcement by Fabio Chianelli, CEO of the biotech company PharmaTher Holdings. The FDA approved orphan drug status for…

Continue Reading Newly FDA Approved Ketamine Has the Potential to Slow ALS Progression